Eric Borges相关文献与解析，生知库 | 链接生命科学的每一步

Activation of the Innate Immune Checkpoint CLEC5A on Myeloid Cells in the Absence of Danger Signals Modulates Macrophages' Function but Does Not Trigger the Adaptive T Cell Immune Response

在没有危险信号的情况下激活髓系细胞上的先天免疫检查点 CLEC5A 会调节巨噬细胞的功能，但不会触发适应性 T 细胞免疫反应

期刊:Journal of Immunology Research

影响因子:3.5

doi:10.1155/2022/9926305

Milena J Tosiek, Kerstin Groesser, Anton Pekcec, Monika Zwirek, Gavuthami Murugesan, Eric Borges

Overcoming tobacco industry opposition to standardized packaging in the Americas

克服烟草业对美洲地区标准化包装的反对

期刊:Revista Panamericana De Salud Publica-Pan American Journal of Public Health

影响因子:2.2

doi:10.26633/RPSP.2022.145

Crosbie, Eric; Borges, Luciana C; Eckford, Robert; Sebrié, Ernesto M; Severini, Gianella; Bialous, Stella A

发表日期：2022

文献求助收藏

Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts

地西他滨增强抗 CD33 单克隆抗体 BI 836858 介导的针对 AML 原始细胞的自然杀伤细胞 ADCC

期刊:Blood

影响因子:21

doi:10.1182/blood-2015-11-680546

Sumithira Vasu, Shun He, Carolyn Cheney, Bhavani Gopalakrishnan, Rajeswaran Mani, Gerard Lozanski, Xiaokui Mo, Veronica Groh, Susan P Whitman, Renate Konopitzky, Christian Kössl, Donna Bucci, David M Lucas, Jianhua Yu, Michael A Caligiuri, William Blum, Paul J Adam, Eric Borges, Bjoern Rueter, Karl-

Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin

BI 836845（一种完全人源 IGF 配体中和抗体）的药效学和抗肿瘤活性以及与雷帕霉素联合使用的机制原理

期刊:Molecular Cancer Therapeutics

影响因子:5.3

doi:10.1158/1535-7163.MCT-13-0598

Katrin Friedbichler, Marco H Hofmann, Monika Kroez, Elinborg Ostermann, Herbert R Lamche, Christian Koessl, Eric Borges, Michael N Pollak, Günther Adolf, Paul J Adam

A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies

一种新型 Fc 工程化 CD37 单克隆抗体，具有增强的 ADCC 和高促凋亡活性，可用于治疗 B 细胞恶性肿瘤

期刊:Blood

影响因子:21

doi:10.1182/blood-2011-04-351932

Karl-Heinz Heider, Kerstin Kiefer, Thorsten Zenz, Matthias Volden, Stephan Stilgenbauer, Elinborg Ostermann, Anke Baum, Herbert Lamche, Zaruhi Küpcü, Alexander Jacobi, Steffen Müller, Ulrich Hirt, Günther R Adolf, Eric Borges

Comment on: Is "pre-sepsis" the new sepsis? A narrative review

评论：脓毒症前期是新的脓毒症吗？一篇叙述性综述

Activation of the Innate Immune Checkpoint CLEC5A on Myeloid Cells in the Absence of Danger Signals Modulates Macrophages' Function but Does Not Trigger the Adaptive T Cell Immune Response

在没有危险信号的情况下激活髓系细胞上的先天免疫检查点 CLEC5A 会调节巨噬细胞的功能，但不会触发适应性 T 细胞免疫反应

Overcoming tobacco industry opposition to standardized packaging in the Americas

克服烟草业对美洲地区标准化包装的反对

Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts

地西他滨增强抗 CD33 单克隆抗体 BI 836858 介导的针对 AML 原始细胞的自然杀伤细胞 ADCC

Pharmacodynamic and antineoplastic activity of BI 836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale for combination with rapamycin

BI 836845（一种完全人源 IGF 配体中和抗体）的药效学和抗肿瘤活性以及与雷帕霉素联合使用的机制原理

A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies

一种新型 Fc 工程化 CD37 单克隆抗体，具有增强的 ADCC 和高促凋亡活性，可用于治疗 B 细胞恶性肿瘤